Vulvovaginal candidiasis.
VVC represents a spectrum of disease. Although there is a clear need for better use of diagnostic modalities and development of better treatment alternatives, most patients with VVC, even the complicated cases, at least have the perspective of achieving adequate control of their symptoms. Future advances, particularly in the area of home diagnostics, may help to optimize use of currently available medicines.
Nyirjesy
Paul
P
Department of Obstetrics and Gynecology, Drexel University College of Medicine, Philadelphia, PA, USA. pnyirjesy@comcast.net
Sobel
Jack D
JD
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D048909:Diabetes Complications; D003937:Diagnosis, Differential; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D012008:Recurrence; D012725:Sexual Behavior
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D004967:Estrogens